Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia

Clinical trial NCT07297550 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07297550
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia Refractory Aplastic Anemia Newly Diagnosed Aplastic Anemia

Start date: 2025-12-15
Primary completion: 2026-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.